These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11365874)

  • 1. New drug proves potent against infections.
    AIDS Alert; 1998 Oct; 13(10):suppl 2-4. PubMed ID: 11365874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic use of cotrimoxazole against opportunistic infections in HIV-positive patients: knowledge and practices of health care providers in Côte d'Ivoire.
    Brou H; Desgrées-du-Loû A; Souville M; Moatti JP; Msellati P;
    AIDS Care; 2003 Oct; 15(5):629-37. PubMed ID: 12959812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.
    Kalou M; Sassan-Morokro M; Abouya L; Bile C; Maurice C; Maran M; Tossou O; Roels T; Greenberg AE; Wiktor SZ; Nkengasong JN
    J Med Virol; 2005 Feb; 75(2):202-8. PubMed ID: 15602734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. District-randomized phased implementation: strengthening the evidence base for cotrimoxazole for HIV-positive tuberculosis patients.
    Godfrey-Faussett P
    AIDS; 2003 May; 17(7):1079-81. PubMed ID: 12700460
    [No Abstract]   [Full Text] [Related]  

  • 5. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi.
    Zachariah R; Spielmann MP; Harries AD; Gomani P; Bakali E
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1046-50. PubMed ID: 12546111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries.
    Zachariah R; Massaquoi M
    Trop Doct; 2006 Apr; 36(2):79-82. PubMed ID: 16611438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Africa: children's access to prophylaxis may improve after medical study, new WHO recommendations.
    Subways S
    AIDS Treat News; 2004; (407-408):8-9. PubMed ID: 15717385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary cryptococcosis: an uncommon opportunistic infection in AIDS on the Ivory Coast].
    Domoua K; Coulibaly G; N'Dhatz MN; Traore F; Vagamon B; Edmond K; Beugre LK; Konan JB; Beaumel A; Yapi A
    Rev Pneumol Clin; 1994; 50(4):184-5. PubMed ID: 7724990
    [No Abstract]   [Full Text] [Related]  

  • 9. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Gill CJ; Sabin LL; Tham J; Hamer DH
    Bull World Health Organ; 2004 Apr; 82(4):290-7. PubMed ID: 15259258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
    Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
    Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in parasitic infections, perceived ill health and access to health care among poorer and less poor schoolchildren of rural Côte d'Ivoire.
    Raso G; Utzinger J; Silué KD; Ouattara M; Yapi A; Toty A; Matthys B; Vounatsou P; Tanner M; N'Goran EK
    Trop Med Int Health; 2005 Jan; 10(1):42-57. PubMed ID: 15655013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCP prevention--more cases of resistance to sulfa drugs.
    TreatmentUpdate; 1998 Sep; 10(7):3-5. PubMed ID: 11365781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cote d'Ivoire: a case study on the impact of HIV / AIDS on health services and households.
    AIDS Anal Afr; 1998 Feb; 8(1):2-3. PubMed ID: 12293288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
    Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
    Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an evidence-based, preventive care package for persons with HIV in Africa.
    Mermin J; Bunnell R; Lule J; Opio A; Gibbons A; Dybul M; Kaplan J
    Trop Med Int Health; 2005 Oct; 10(10):961-70. PubMed ID: 16185230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thresholds of CD4 cells for initiating trimethoprim-sulfamethoxazole prophylaxis in west Africa.
    Anglaret X; Toure S; Ouassa T; Dabis F; N'Dri-Yoman T
    AIDS; 2000 Nov; 14(16):2628-9. PubMed ID: 11101085
    [No Abstract]   [Full Text] [Related]  

  • 17. Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi.
    Zachariah R; Harries AD; Arendt V; Wennig R; Schneider S; Spielmann M; Panarotto E; Gomani P; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):843-6. PubMed ID: 11573896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactrim approved for prophylaxis.
    AIDS Patient Care; 1994 Jun; 8(3):166. PubMed ID: 11362143
    [No Abstract]   [Full Text] [Related]  

  • 19. Cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Graham SM
    Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV / AIDS country profile: Cote d'Ivoire. Risk analysis.
    Da Camara-gomes F
    AIDS Anal Afr; 1997 Apr; 7(2):12-4. PubMed ID: 12290341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.